ask our doctors

Polymyositis

Get the facts on Polymyositis treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Polymyositis prevention, screening, research, statistics and other Polymyositis related topics. We answer all your qestions about Polymyositis.

Question: Where is the best treatment available for Polymyositis? Can anyone help me by providing information on hospitals in the US or anywhere else in the world where good treatment for Polymyositis is available?. Any help will be appreciated! Thanks!

Answer: Polymyositis is a type of inflammatory myopathy, related to dermatomyositis and inclusion body myositis. Polymyositis means 'many muscle inflammation'. Polymyositis tends to become evident in adulthood, presenting with bilateral proximal muscle weakness, often noted in the upper legs due to early fatigue while walking. Sometimes the weakness presents itself by the person being unable to rise from a seated position without help, or inability to raise their arms above their head. The weakness is generally progressive, accompanied by lymphocytic inflammation (mainly cytotoxic T8 lymphocytes). The cause is unknown, but seems to be related to autoimmune factors, genetics, and perhaps viruses. In rare cases, the cause is known to be infectious, associated with the pathogens that cause Lyme disease, toxoplasmosis, and others. Polymyositis, like dermatomyositis, strikes females with greater frequency than males. The skin involvement of dermatomyositis is absent in polymyositis. Diagnosis is fourfold, including elevation of creatine kinase, signs and symptoms, electromyograph (EMG) alteration, and a positive muscle biopsy. Treatment generally involves glucocorticoids, especially prednisone. Unfortunately very few in the medical profession are familiar enough with the disease to be able to accurately diagnose it in the early stages. Therefore many patients go undiagnosed for years, suffering needlessly. Sporadic inclusion body myositis (sIBM): IBM is often confused with (misdiagnosed as) polymyositis and polymyositis that does not respond to treatment is likely IBM. sIBM comes on over months to years, polymyositis comes on over weeks to months. It appears that sIBM and polymyositis share some common features, especially the initial sequence of immune system activation, however, polmyositis does not display the subsequent muscle degeneration and protein abnormalities as seen in IBM. As well, polymyositis tends to respond well to treatments, IBM does not. IBM and polymyositis apparently involve different disease mechanisms than are seen in dermatomyositis. The link below has some suggestions on treatments.


Polymyositis News

Questcor Pharmaceuticals Expands Repurchase Program

MarketWatch (press release)
Questcor is also currently preparing to launch a pilot effort in rheumatology, as Acthar is approved for several rheumatology-related conditions including Lupus, Dermatomyositis, Polymyositis and Rheumatoid Arthritis. Questcor is also exploring the ...
 

Questcor Pharmaceuticals Expands Repurchase Program

PR Newswire (press release)
Questcor is also currently preparing to launch a pilot effort in rheumatology, as Acthar is approved for several rheumatology-related conditions including Lupus, Dermatomyositis, Polymyositis and Rheumatoid Arthritis. Questcor is also exploring the ...
 

Questcor's CEO Presents at Bank of America Merrill Lynch 2012 Health Care ...

Seeking Alpha
I have listed four here that are rather are the most interesting lupus condition called PMDM or polymyositis/dermatomyositis, psoriatic arthritis and rheumatoid arthritis. Again there is a high unmet need. It is difficult to treat conditions.
 

Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 ...

MarketWatch (press release)
Questcor is also currently planning to explore the potential initiation of a commercial effort in rheumatology, as Acthar is approved for several rheumatology-related conditions including Lupus, Dermatomyositis, Polymyositis and Rheumatoid Arthritis.
 

Questcor Reports First Quarter 2012 Financial Results

Daily Markets
Collagen Diseases: ?during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus, systemic dermatomyositis (polymyositis).? Rheumatic Disorders: ?as adjunctive therapy for short-term administration (to tide the ...
 

Newsolio

What is Scleroderma (Systemic Sclerosis)?
Newsolio
 

India Today

The healing power of choice
India Today
 

MDA Supports Development of 'Dissociative Glucocorticoid' for DMD

MarketWatch (press release)
Examples are myasthenia gravis (MG), dermatomyositis (DM), polymyositis (PM), asthma and rheumatoid arthritis. ReveraGen has tested VB15 in mice with a DMD-like disease and has found it improved muscle function and reduced muscle inflammation.
 

MDA Supports Development of 'Dissociative Glucocorticoid' for DMD

PR Newswire (press release)
Examples are myasthenia gravis (MG), dermatomyositis (DM), polymyositis (PM), asthma and rheumatoid arthritis. ReveraGen has tested VB15 in mice with a DMD-like disease and has found it improved muscle function and reduced muscle inflammation.